+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etoposide"

Small Cell Lung Cancer Therapeutics Global Market Report 2024 - Product Thumbnail Image

Small Cell Lung Cancer Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Etoposide is a chemotherapy drug used to treat a variety of cancers, including lung cancer. It is a type of topoisomerase inhibitor, which works by blocking the action of an enzyme that helps cancer cells divide and grow. Etoposide is typically used in combination with other drugs, such as cisplatin, to treat advanced or metastatic lung cancer. It is also used to treat small cell lung cancer, which is an aggressive form of the disease. Etoposide is available in both oral and intravenous forms, and is typically administered in cycles of several weeks. Common side effects of the drug include nausea, vomiting, hair loss, and fatigue. The etoposide market is highly competitive, with several major pharmaceutical companies offering the drug. These include Bristol-Myers Squibb, Pfizer, and Merck. Other companies, such as Teva Pharmaceuticals and Sun Pharmaceuticals, also offer generic versions of the drug. Show Less Read more